Supercharged immune cells show promise in Hard-to-Treat gynecologic cancers
NCT ID NCT05468307
First seen Jan 06, 2026 · Last updated May 14, 2026 · Updated 22 times
Summary
This study tested a new treatment for people with advanced gynecologic tumors that had stopped responding to standard therapies. Doctors took immune cells from each patient's tumor, modified them in the lab to make them stronger, and then infused them back into the patient. The goal was to see if this approach was safe and could shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT SIDE EFFECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.